Regardless of the type of psychotropic medication used to treat patients with bipolar disorder, outcomes are about the same at 1 year, a retrospective chart review from the University of Toledo suggests. All 121 patients in the study were treated with a mood stabilizer. Some of them had an added antipsychotic, and a significant number also had an antidepressant, lead author Dr. Ronald A. McGinnis said at the annual meeting of the American Psychiatric Association. Across the board, the findings proved consistent. “We found no medication regimen superior to any other,” he said.
